Detalhe da pesquisa
1.
The National Lung Matrix Trial of personalized therapy in lung cancer.
Nature;
583(7818): 807-812, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32669708
2.
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer.
Nature;
585(7826): E21, 2020 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32887973
3.
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial.
Lancet Oncol;
23(3): 374-381, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35157829
4.
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial.
Lancet Oncol;
23(4): 540-552, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35358455
5.
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer.
Br J Cancer;
126(8): 1157-1167, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34912072
6.
The Clinical Frailty Scale can indicate prognosis and care requirements on discharge in oncology and haemato-oncology inpatients: A cohort study.
Eur J Cancer Care (Engl);
31(6): e13752, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36286099
7.
Practical implications to contemplate when considering radical therapy for stage III non-small-cell lung cancer.
Br J Cancer;
123(Suppl 1): 28-35, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33293673
8.
Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper.
Br J Cancer;
123(6): 874-884, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32694695
9.
Correction: A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965.
Br J Cancer;
122(8): 1272, 2020 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32203218
10.
A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965.
Br J Cancer;
122(8): 1141-1145, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32076124
11.
Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours.
Br J Cancer;
123(9): 1360-1369, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32741975
12.
Are there socio-economic inequalities in utilization of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysis.
BMC Med;
18(1): 282, 2020 10 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33092592
13.
A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours.
Br J Cancer;
120(10): 975-981, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30992546
14.
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours.
Br J Cancer;
120(4): 379-386, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30679780
15.
SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting.
Br J Cancer;
117(7): 938-946, 2017 Sep 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28950288
16.
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis.
Eur Urol Oncol;
7(2): 179-188, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37574390
17.
Histology independent drug development - Is this the future for cancer drugs?
Cancer Treat Rev;
123: 102674, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38176220
18.
A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors.
Cancer Med;
13(5)2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38501219
19.
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
J Clin Oncol;
42(2): 192-204, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38039427
20.
First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase 1b/2 JAVELIN Chemotherapy Medley study.
Cancer Res Commun;
2024 Apr 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38669053